Fig. 3From: Single protein encapsulated SN38 for tumor-targeting treatmentMouse BW changes vs days after treatment for SPESN38-5 on Day 1, A PO route at 250Â mg/kg; B PO route at 200Â mg/kg; C IV route at 55Â mg/kg; D IV route at 50Â mg/kg; E IV route at 45Â mg/kg; F IV route at 35Â mg/kg. The experiments at high doses were done with 2 mice/group to map the MTD range. At near MTD doses, 4 mice/group were usedBack to article page